aTyr Pharma
ATYR
2,40 €
Share price
-6.09%
Change (1 day)
42.12%
Change (1 year)
Categories
P/S ratio for aTyr Pharma (ATYR)
P/S ratio as of April 2025 (TTM): 991
According to aTyr Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.33. At the end of 2024 the company had a P/S ratio of > 1000.
P/S ratio history for aTyr Pharma from 2015 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | > 1000 | 471.14% |
| 2023 | 234 | 3723.94% |
| 2022 | 6.12 | |
| 2021 | N/A | -100% |
| 2020 | 4.09 | -89.37% |
| 2019 | 38.5 | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 5.06 | -99.49% | 🇺🇸 USA |
 | 11.1 | -98.88% | 🇺🇸 USA |